Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report) traded up 0.7% during mid-day trading on Thursday . The company traded as high as $7.34 and last traded at $7.00. 3,619 shares traded hands during mid-day trading, an increase of 47% from the average session volume of 2,464 shares. The stock had previously closed at $6.95.
Clinuvel Pharmaceuticals Trading Up 0.7 %
The stock’s 50-day simple moving average is $7.22 and its 200-day simple moving average is $7.97.
Clinuvel Pharmaceuticals Company Profile
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Featured Articles
- Five stocks we like better than Clinuvel Pharmaceuticals
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Upcoming IPO Stock Lockup Period, Explained
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Clinuvel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinuvel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
